The invention relates to a process for preparing cannabinoid-containing particles, wherein first a solution is provided wherein the solvent has a water solubility in the range of 2-100 g/L at 25° C. and wherein the solution comprises 1) a cannabinoid component comprising one or more cannabinoids; and 2) a shell-forming component comprising one or more compounds selected from the group of C10-C30 fatty alcohols. C10-C30 fatty acids and esters of C10-C30 fatty alcohols and C10-C30 fatty acids. Then, droplets of the solution are generated in an aqueous medium and the solvent is allowed to migrate from the droplets to the aqueous medium to thereby form solid particles wherein a shell of shell-forming component encapsulates the cannabinoid component.
The invention relates to process for preparing cannabinoid-containing particles, wherein first a solution is provided wherein the solvent has a water solubility in the range of 2-100 g/L at 25° C. and wherein the solution comprises 1) a cannabis component comprising THC; and 2) a shell-forming component comprising one or more compounds selected from the group of C10-C30 fatty alcohols, C10-C30 fatty acids and esters of C10-C30 fatty alcohols and C10-C30 fatty acids. Then, droplets of the solution are generated in an aqueous medium and the solvent is allowed to migrate from the droplets to the aqueous medium to thereby form solid particles wherein a shell of shell-forming component encapsulates the cannabis component.
A61K 31/352 - Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. cannabinols, methantheline
3.
PROCESS FOR PREPARING CANNABINOID-CONTAINING PARTICLES
The invention relates to a process for preparing cannabinoid-containing particles, wherein first a solution is provided wherein the solvent has a water solubility in the range of 2100 g/L at 25 °C and wherein the solution comprises 1) a cannabinoid component comprising one or more cannabinoids; and 2) a shell-forming component comprising one or more compounds selected from the group of C10C30 fatty alcohols, C10C30 fatty acids and esters of C10C30 fatty alcohols and C10C30 fatty acids. Then, droplets of the solution are generated in an aqueous medium and the solvent is allowed to migrate from the droplets to the aqueous medium to thereby form solid particles wherein a shell of shell-forming component encapsulates the cannabinoid component.
A61K 31/352 - Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. cannabinols, methantheline
A61K 47/14 - Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
The invention relates to a process for preparing cannabinoid-containing particles, wherein first a solution is provided wherein the solvent has a water solubility in the range of 2–100 g/L at 25 °C and wherein the solution comprises 1) a cannabinoid component comprising one or more cannabinoids; and 2) a shell-forming component comprising one or more compounds selected from the group of C10–C30 fatty alcohols, C10–C30 fatty acids and esters of C10–C30 fatty alcohols and C10–C30 fatty acids. Then, droplets of the solution are generated in an aqueous medium and the solvent is allowed to migrate from the droplets to the aqueous medium to thereby form solid particles wherein a shell of shell-forming component encapsulates the cannabinoid component.
A61K 31/352 - Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. cannabinols, methantheline
A61K 47/14 - Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
The invention relates to a process for preparing particles comprising an encapsulated lipid, wherein first a solution is provided wherein the solvent has a water solubility in the range of 2–100 g/L at 25 °C and wherein the solution comprises 1) a lipid component comprising one or more lipids; and 2) a shell- forming component comprising one or more compounds selected from the group of C10–C30 fatty alcohols, C10–C30 fatty acids and esters of C10–C30 fatty alcohols and C10–C30 fatty acids. Then, droplets of the solution are generated in an aqueous medium and the solvent is allowed to migrate from the droplets to the aqueous medium to thereby form solid particles wherein a shell of shell- forming component encapsulates the lipid component.
The invention relates to process for preparing cannabinoid-containing particles, wherein first a solution is provided wherein the solvent has a water solubility in the range of 2–100 g/L at 25 °C and wherein the solution comprises 1) a cannabis component comprising THC; and 2) a shell-forming component comprising one or more compounds selected from the group of C10–C30 fatty alcohols, C10–C30 fatty acids and esters of C10–C30 fatty alcohols and C10–C30 fatty acids. Then, droplets of the solution are generated in an aqueous medium and the solvent is allowed to migrate from the droplets to the aqueous medium to thereby form solid particles wherein a shell of shell-forming component encapsulates the cannabis component.
A61K 31/352 - Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. cannabinols, methantheline
patents
